Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2009

01-01-2009 | Bone and Soft Tissue Sarcomas

Postoperative Infection and Survival in Osteosarcoma Patients

Authors: Jun Ah Lee, Min Suk Kim, Dong Ho Kim, Jung Sub Lim, Kyung Duk Park, Wan Hyeong Cho, Won Seok Song, Soo-Yong Lee, Dae-Geun Jeon

Published in: Annals of Surgical Oncology | Issue 1/2009

Login to get access

Abstract

The clinical impact of postoperative deep infection on survival remains controversial in osteosarcoma patients. The authors identified 31 osteosarcoma patients that developed a deep infection within 1 year of operation between 1990 and 2003, and compared clinicopathologic characteristics of 31 patients that developed an infection with those of 316 patients that did not. For survival analysis, 62 noninfected patients matched for prognostic factors such as histologic response, tumor size, and location were also selected. In infected patients, although it was not significant due to the small patient numbers, good response to preoperative chemotherapy and a proximal tibial location were frequently observed. No local recurrence developed in infected patients. Five-year overall and metastasis-free survival rates for the 31 infected patients were as high as 89% and 73%, respectively. However, after matching for clinical factors, no survival difference was noted between infected and noninfected patients. Deep infection has a multifaceted effect on patients. However, the present study suggests that the reported positive effect on survival is likely to be related to the clinical characteristics of infected patients rather than an antitumor effect due to the infection. Further investigations are needed to clarify the precise effects of infection.
Literature
1.
go back to reference Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 1990;29:545–50.CrossRefPubMed Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 1990;29:545–50.CrossRefPubMed
2.
go back to reference Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013–7.CrossRefPubMed Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013–7.CrossRefPubMed
3.
go back to reference Schantz SP, Skolnik EM, O’Neill JV. Improved survival associated with postoperative wound infection in laryngeal cancer: an analysis of its therapeutic implications. Otolaryngol Head Neck Surg. 1980;88:412–7.CrossRefPubMed Schantz SP, Skolnik EM, O’Neill JV. Improved survival associated with postoperative wound infection in laryngeal cancer: an analysis of its therapeutic implications. Otolaryngol Head Neck Surg. 1980;88:412–7.CrossRefPubMed
4.
go back to reference Wiemann B, Starnes CO. Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther. 1994;64:529–64.CrossRefPubMed Wiemann B, Starnes CO. Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther. 1994;64:529–64.CrossRefPubMed
5.
go back to reference American Cancer Society. Guide to complementary and alternative cancer methods. Atlanta: American Cancer Society; 2000. American Cancer Society. Guide to complementary and alternative cancer methods. Atlanta: American Cancer Society; 2000.
7.
go back to reference Nespoli A, Gianotti L, Totis M, Bovo G, Nespoli L, Chiodini P, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori. 2004;90:485–90.PubMed Nespoli A, Gianotti L, Totis M, Bovo G, Nespoli L, Chiodini P, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori. 2004;90:485–90.PubMed
8.
go back to reference Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, Garden OJ, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer. 1995;75:2077–82.CrossRefPubMed Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, Garden OJ, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer. 1995;75:2077–82.CrossRefPubMed
9.
go back to reference Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF, et al. C-reactive protein serum level is a valuable and simple prognostic marker in non hodgkin’s lymphoma. Leuk Lymphoma. 1998;31:351–7.CrossRefPubMed Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF, et al. C-reactive protein serum level is a valuable and simple prognostic marker in non hodgkin’s lymphoma. Leuk Lymphoma. 1998;31:351–7.CrossRefPubMed
10.
go back to reference Gorelick MH, Owen WC, Seibel NL, Reaman GH. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J. 1991;10:506–10.CrossRefPubMed Gorelick MH, Owen WC, Seibel NL, Reaman GH. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J. 1991;10:506–10.CrossRefPubMed
11.
go back to reference Shin DS, Weber KL, Chao EY, An KN, Sim FH. Reoperation for failed prosthetic replacement used for limb salvage. Clin Orthop Relat Res. 1999;358:53–63.CrossRefPubMed Shin DS, Weber KL, Chao EY, An KN, Sim FH. Reoperation for failed prosthetic replacement used for limb salvage. Clin Orthop Relat Res. 1999;358:53–63.CrossRefPubMed
12.
go back to reference Wirganowicz PZ, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM. Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res. 1999;358:64–74.CrossRefPubMed Wirganowicz PZ, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM. Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res. 1999;358:64–74.CrossRefPubMed
13.
go back to reference Lascelles BD, Dernell WS, Correa MT, et al. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol. 2005;12:1073–83.CrossRefPubMed Lascelles BD, Dernell WS, Correa MT, et al. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol. 2005;12:1073–83.CrossRefPubMed
14.
go back to reference Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887–95.CrossRefPubMed Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887–95.CrossRefPubMed
15.
go back to reference Kim MS, Cho WH, Song WS, Lee SY, Jeon DG. Time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res. 2007;463:157–65.PubMed Kim MS, Cho WH, Song WS, Lee SY, Jeon DG. Time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res. 2007;463:157–65.PubMed
16.
go back to reference Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol. 1983;106(Suppl):55–67.CrossRefPubMed Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol. 1983;106(Suppl):55–67.CrossRefPubMed
17.
19.
go back to reference McAuley JP, Moore KD, Culpepper WJ 2nd, Engh CA. Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am. 1998;80:1648–55.PubMed McAuley JP, Moore KD, Culpepper WJ 2nd, Engh CA. Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am. 1998;80:1648–55.PubMed
21.
go back to reference Vannini P, Ciavarella A, Olmi R, Flammini M, Moroni A, Galuppi V, et al. Diabetes as pro-infective risk factor in total hip replacement. Acta Diabetol Lat. 1984;21:275–80.CrossRefPubMed Vannini P, Ciavarella A, Olmi R, Flammini M, Moroni A, Galuppi V, et al. Diabetes as pro-infective risk factor in total hip replacement. Acta Diabetol Lat. 1984;21:275–80.CrossRefPubMed
22.
go back to reference Saleh K, Olson M, Resig S, et al. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002;20:506–15.CrossRefPubMed Saleh K, Olson M, Resig S, et al. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002;20:506–15.CrossRefPubMed
23.
go back to reference Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459–69.CrossRefPubMed Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459–69.CrossRefPubMed
24.
go back to reference Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0–16 years in the Norwegian arthroplasty register. Acta Orthop. 2006;77:351–8.CrossRefPubMed Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0–16 years in the Norwegian arthroplasty register. Acta Orthop. 2006;77:351–8.CrossRefPubMed
Metadata
Title
Postoperative Infection and Survival in Osteosarcoma Patients
Authors
Jun Ah Lee
Min Suk Kim
Dong Ho Kim
Jung Sub Lim
Kyung Duk Park
Wan Hyeong Cho
Won Seok Song
Soo-Yong Lee
Dae-Geun Jeon
Publication date
01-01-2009
Publisher
Springer New York
Published in
Annals of Surgical Oncology / Issue 1/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0184-8

Other articles of this Issue 1/2009

Annals of Surgical Oncology 1/2009 Go to the issue